M. Anson, A. M. Crain-denoyelle, V. Baud, F. Chereau, A. Gougelet et al., Oncogenic ?-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice, Journal of Clinical Investigation, vol.122, issue.2, pp.586-599, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02532857

J. Bayo, A. Real, E. J. Fiore, M. Malvicini, L. Sganga et al., IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness, Oncotarget, vol.8, issue.46, pp.80235-80248, 2016.

C. Berasain and M. A. Avila, Deciphering liver zonation: New insights into the ?-catenin, Tcf4, and HNF4? triad, Hepatology, vol.59, issue.6, pp.2080-2082, 2014.

A. Budhu and X. W. Wang, The role of cytokines in hepatocellular carcinoma, Journal of Leukocyte Biology, vol.80, issue.6, pp.1197-1213, 2006.

A. De-la-coste, B. Romagnolo, P. Billuart, C. A. Renard, M. A. Buendia et al., Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas, Proc Natl Acad Sci, vol.95, pp.8847-8851, 1998.

R. Désert, S. Mebarki, M. Desille, M. Sicard, E. Lavergne et al., ?Fibrous nests? in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome, The International Journal of Biochemistry & Cell Biology, vol.81, pp.195-207, 2016.

R. Désert, N. Nieto, and O. Musso, Dimensions of hepatocellular carcinoma phenotypic diversity, World Journal of Gastroenterology, vol.24, issue.40, pp.4536-4547, 2018.

R. Désert, F. Rohart, F. Canal, M. Sicard, M. Desille et al., Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection, Hepatology, vol.66, issue.5, pp.1502-1518, 2017.

H. Dubois?pot?schneider, K. Fekir, C. Coulouarn, D. Glaise, C. Aninat et al., Inflammatory cytokines promote the retrodifferentiation of tumor?derived hepatocyte?like cells to progenitor cells, Hepatology, vol.60, issue.6, pp.2077-2090, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01134747

, Corrigendum to ?EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma? [J Hepatol 69 (2018) 182?236], Journal of Hepatology, vol.70, issue.4, p.817, 2019.

C. Estes, Q. M. Anstee, M. T. Arias-loste, H. Bantel, S. Bellentani et al., Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016?2030, Journal of Hepatology, vol.69, issue.4, pp.896-904, 2018.

S. and R. H. , United Kingdom, and United States for the period, Journal of hepatology, vol.69, pp.896-904, 2016.

C. Estes, H. Razavi, R. Loomba, Z. Younossi, and A. J. Sanyal, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, vol.67, issue.1, pp.123-133, 2017.

A. Forner, M. Reig, and J. Bruix, Hepatocellular carcinoma, The Lancet, vol.391, issue.10127, pp.1301-1314, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01134844

D. Goldberg, I. C. Ditah, K. Saeian, M. Lalehzari, A. Aronsohn et al., Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation, Gastroenterology, vol.152, issue.5, pp.1090-1099.e1, 2017.

A. Gougelet, C. Torre, P. Veber, C. Sartor, L. Bachelot et al., T-cell factor 4 and ?-catenin chromatin occupancies pattern zonal liver metabolism in mice, Hepatology, vol.59, issue.6, pp.2344-2357, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02532861

A. L?hermitte, S. Pham, M. Cadoux, G. Couchy, S. Caruso et al., Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma, Hepatology, vol.69, issue.1, pp.160-178, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02532127

M. , C. , S. Yamagoe, S. Zucman-rossi, and J. , Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma: Hepatobiliary Malignancies, Hepatology, vol.69, pp.160-178, 2019.

J. Liu, H. Dang, and X. W. Wang, The significance of intertumor and intratumor heterogeneity in liver cancer, Experimental & Molecular Medicine, vol.50, issue.1, pp.e416-e416, 2018.

J. M. Llovet, J. Zucman-rossi, E. Pikarsky, B. Sangro, M. Schwartz et al., Hepatocellular carcinoma, Nature Reviews Disease Primers, vol.2, issue.1, p.16018, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01910322

S. Mebarki, R. Désert, L. Sulpice, M. Sicard, M. Desille et al., De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas, Oncotarget, vol.7, issue.26, pp.39026-39043, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01335675

C. K. Ng, S. Piscuoglio, and L. M. Terracciano, Molecular classification of hepatocellular carcinoma: The view from metabolic zonation, Hepatology, vol.66, issue.5, pp.1377-1380, 2017.

N. Nishida and M. Kudo, Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication, Oncology, vol.92, issue.1, pp.40-49, 2016.

R. Nusse and H. Clevers, Wnt/?-Catenin Signaling, Disease, and Emerging Therapeutic Modalities, Cell, vol.169, issue.6, pp.985-999, 2017.

T. Poynard, P. Bedossa, and P. Opolon, Natural history of liver fibrosis progression in patients with chronic hepatitis C, The Lancet, vol.349, issue.9055, pp.825-832, 1997.

K. Rubin, A. Janefeldt, L. Andersson, Z. Berke, K. Grime et al., HepaRG Cells as Human-Relevant In Vitro Model to Study the Effects of Inflammatory Stimuli on Cytochrome P450 Isoenzymes, Drug Metabolism and Disposition, vol.43, issue.1, pp.119-125, 2014.

. Cytochrome and . Isoenzymes, Drug Metabolism and Disposition, vol.43, pp.119-125, 2014.

D. Rouède, E. Schaub, J. Bellanger, F. Ezan, J. Scimeca et al., Determination of extracellular matrix collagen fibril architectures and pathological remodeling by polarization dependent second harmonic microscopy, Scientific Reports, vol.7, issue.1, 2017.

P. Ruytinx, P. Proost, J. Van-damme, and S. Struyf, Chemokine-Induced Macrophage Polarization in Inflammatory Conditions, Frontiers in Immunology, vol.9, p.1, 2018.

M. Seehawer, F. Heinzmann, L. D?artista, J. Harbig, P. Roux et al., Necroptosis microenvironment directs lineage commitment in liver cancer, Nature, vol.562, issue.7725, pp.69-75, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02348982

M. Sherman and J. Bruix, Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice, Hepatology, vol.61, issue.2, pp.433-436, 2015.

K. Schulze, S. Imbeaud, E. Letouzé, L. B. Alexandrov, J. Calderaro et al., Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, Nature Genetics, vol.47, issue.5, pp.505-511, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01159736

D. Sia, Y. Jiao, I. Martinez-quetglas, O. Kuchuk, C. Villacorta-martin et al., Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features, Gastroenterology, vol.153, issue.3, pp.812-826, 2017.

T. Tsujikawa, S. Kumar, R. N. Borkar, V. Azimi, G. Thibault et al., Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis, Cell Reports, vol.19, issue.1, pp.203-217, 2017.

J. Waisberg and G. T. Saba, Wnt-/-?-catenin pathway signaling in human hepatocellular carcinoma, World Journal of Hepatology, vol.7, issue.26, p.2631, 2015.

K. E. Wiese, R. Nusse, and R. Van-amerongen, Wnt signalling: conquering complexity, Development, vol.145, issue.12, p.dev165902, 2018.

J. Zucman-rossi, A. Villanueva, J. C. Nault, and J. M. Llovet, Genetic Landscape and Biomarkers of Hepatocellular Carcinoma, Gastroenterology, vol.149, issue.5, pp.1226-1239.e4, 2015.

J. Zucman-rossi, S. Benhamouche, C. Godard, S. Boyault, G. Grimber et al., Differential effects of inactivated Axin1 and activated ?-catenin mutations in human hepatocellular carcinomas, Oncogene, vol.26, issue.5, pp.774-780, 2006.